Ceapro Receives BIOTECanada Gold Leaf Award
Emerging Company of the Year-Industry and Agriculture
SAN DIEGO, CALIFORNIA -- (Marketwired) -- 06/25/14 --
Ceapro Inc. (TSX VENTURE:CZO) ("Ceapro" or the "Company") today received a prestigious Gold Leaf Award as a recognition from its peers for its innovative work in the Canadian Industry and Agriculture market segment. The award was received in the presence of Alberta Premier, the Honourable Dave Hancock, and President & CEO of Novo Nordisk Canada, Mr. Vince Lamanna, during the BIO International Convention being held in San Diego.
"We are delighted and honoured to receive this prestigious award. Our employees worked hard in the building of our Company over the last years and I am extremely grateful to them. I also wish to thank BIOTECanada and the selection committee who have recognized Ceapro's accomplishments amongst Canadian success stories and of course our partners, Agriculture and Agri-Food Canada, AIberta Innovates Bio Solutions, Agriculture Financial Services Corporation, Symrise AG as well as our Board and shareholders for their continued support over the years," said Gilles Gagnon, President & CEO of Ceapro. "I keep repeating that it takes years to build a company 'brick by brick'. We now have a solid foundation for growth and are ready to surge," he added.
About Ceapro Inc.
Ceapro Inc. is a Canadian growth-stage biotechnology company. Primary business activities relate to the development and commercialization of active ingredients for personal care and healthcare industries using proprietary technology and natural, renewable resources. To learn more about Ceapro, visit www.ceapro.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Megan Lee, Ph.D., MBA
Director of Corporate Affairs, Planning & Development
Source: Ceapro Inc.
Released June 25, 2014